Trumenba 60 ug/.5mL

Trumenba 60 ug/0.5mL is a meningococcal group B vaccine designed to help prevent infections caused by the meningococcal group B bacteria. This intramuscular injection is suitable for individuals at risk of meningococcal disease.

Trumenba is used to protect against meningococcal group B infections, which can lead to serious conditions like meningitis and sepsis. This vaccine is typically recommended for individuals aged 10 to 25 years, particularly those at higher risk due to specific health conditions or lifestyle factors. The vaccine works by stimulating the immune system to produce antibodies against the meningococcal group B bacteria.

Common effects of Trumenba may include mild to moderate reactions at the injection site, such as pain, redness, or swelling. Some individuals may also experience general symptoms like fatigue, headache, or muscle pain. These effects are usually temporary and resolve within a few days.

Trumenba should be administered by healthcare professionals trained in vaccination procedures. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it. It is important to inform the healthcare provider about any current illnesses or allergies before receiving the vaccine.

Trumenba may interact with other medications or vaccines. It is advisable to discuss all current medications with a healthcare provider before receiving the vaccine. Specific interactions with over-the-counter drugs, herbal supplements, or other vaccines should be evaluated by a healthcare professional.